Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping

Blood

Volumn 92, Issue 11, 1998, Pages 4269-4278

  Sawyer, Jeffrey R ^a   Lukacs, Janet L ^b   Munshi, Nikhil ^b   Desikan, K Raman ^b   Singhal, Seema ^b   Mehta, Jayesh ^b   Siegel, David ^b   Shaughnessy, John ^b   Barlogie, Bart ^b  

^a ARKANSAS CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW; CANCER GENETICS; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 16; CHROMOSOME TRANSLOCATION 6; CHROMOSOME TRANSLOCATION 8; CHROMOSOME TRANSLOCATION 9; CLINICAL ARTICLE; DISEASE ASSOCIATION; HUMAN; KARYOTYPING; LYMPHOMA; MULTIPLE MYELOMA; PRIORITY JOURNAL; WALDENSTROEM MACROGLOBULINEMIA;

EID: 0032402134     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.11.4269.423k31_4269_4278     Document Type: Article

References (25)

1. Heim S, Mitelman F: Chronic lymphoproliferative disorders, in Cancer Cytogenetics. New York, NY, Liss, 1995, p 237
2. Sandberg AA: The Chromosomes in Human Cancer and Leukemia (ed 2). New York, NY, Elsevier, 1990, p 649
3. DeWald GW, Kyle RA, Hicks GA, Greip PR: The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia or amyloidosis. Blood 66:380, 1985
4. Van den Berghe H, Vermaelen K, Louwagie A, Criel A, Mecucci C, Vaerman J-P: High incidence of chromosome abnormalities in IgGA myeloma. Cancer Genet Cytogenet 11:381, 1984
5. Chesi M, Nardini E, Breants LA, SchrockE, Reid T, Kueho WM, Bergsagel PL: Frequent translocation of t(4;14)(p16.3;q32) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 16:260, 1997
6. Ida S, Rao PH, Butler M, Corradini P, Boccadors M, Klien B, Chaganti RSK, Dalla-Favera R: Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nat Genet 17:226, 1997
7. Chesi M, Shonukan O, Brents LA, Bergsagel PL, Kuehl WM: Recurrent t(14;16)(q32.3;q23) translocation associated with c-maf overexpression in multiple myeloma. Proc Am Assoc Cancer Res 39: 471A, 1998(abstr)
8. Bergsagel PL, Chesi M, Nardini E, Brents LA, Kirby SL, Kuehl WM: Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. Proc Natl Acad Sci USA 93:13931. 1996
9. Speicher MR, Ballard SG, Ward DC: Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet 14:312, 1996
10. Schrock E, duManoir S, Veldman T, Schoell Weinberg J, Ferguson-Smith MA, Ning Y, Ledbetter DH, Bar-Am I, Soenkensen D, Barini Y, Reid T: Multicolor spectral karyotyping of human chromosomes. Science 273:494, 1996
11. Veldman T, Vignon C, Schrock E, Rowley JD, Reid T: Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping. Nat Genet 15:406, 1997
12. Rao PH, Cigudos J, Ning Y, Calasanz MJ, Tagawa S, Michaele S, Klein B, Dalla-Favera R, Reid T, Chaganti RSK: Karyotypic complexity of multiple myeloma defined by multicolor spectral karyotyping (SKY). Blood 90:87a, 1997 (abstr, suppl 1)
13. Sawyer JR, Waldron JA, Jagannath S, Barlogie B: Cytogenetic findings in 200 patients with multiple myeloma. Cancer Genet Cytogenet 82:41, 1995
14. ISCN (1995): Mitelman F (ed): Guidelines for Cancer Cytogenetics, Supplement to an International System for Human Cytogenetic Nomenclature. Basel, Switzerland, Karger, 1995
15. Telenius H, Pelmear AH, Tunnacliffe A, Carter NP, Behmel A, Ferguson-Smith MA, Norderskjold M, Pfragner R. Ponder BAJ: Cytogenetic analysis by chromosome painting using DOP-PCR amplified flow sorted chromosomes. Genes Chromosomes Cancer 4:257, 1992
16. Garini Y, Macville M, Du Manoir S, Buckwald RA, Lavi M, Katzir N, Wine D, Bar-AM I, Schrock E, Cabib D, Reid T: Spectral karyotyping. Bioimaging 4:65, 1996
17. Calasanz MJ, Cigudosa JC, Odero MD, Ferreira C, Ardanaz MT, Fraile A, Carrasco JL, Sole F, Braulia C, Gullon A: Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: Primary breakpoints and clinical correlations. Genes Chromosomes Cancer 18:84, 1997
18. Offit K, Parsa NZ, Filippa D, Jhanwar SC, Chaganti RSK: t(9;14)(p13;q32) denotes a subset of low-grade non-Hodgkin's lymphoma with plasmacytoid differentiation. Blood 80:2594, 1992
19. Iida S, Rao PH, Nallasivam P, Hibshoosh H, Butler M, Louie DC, Dyomin V, Ohno H, chaganti RSK, Dalla-Favera R: The t(9;14)(p13; q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. Blood 88:4110, 1996
20. Bergsagel PL, Nardini E, Breants L, Chesti M, Kuehl WMI: IgH translocations in multiple myeloma: A nearly universal event that rarely involves c-myc. Curr Top Microbiol Immunol 224:283, 1997
21. Willis TG, Zalcberg IR, Coignet LJA, Wlodarska I, Stul M, Jadayel DM, Bastard C, Treleaven JG, Catovsky D, Suva MLM, Dyer MJS: Molecular cloning of translocation t(1;14)(q21;q32) defines a novel gene (BCL9) at chromosome 1q21. Blood 91:1873, 1998
22. Jonveauz P, Berger R: Chromosome studies in plasma cell leukemia and multiple myeloma in transformation. Genes Chromosomes Cancer 4;321, 1992
23. Hallek M, Bergsagel PL, Anderson KC: Multiple myeloma: Increasing evidence for a multistep transformation process. Blood 91:3, 1998
24. Tricot G, Barlogie B, Jagannath S, Bracy D, Mattox S, Vesole DH, Naucke S, Sawyer JR: Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities. Blood 86:4250, 1995
25. Tricot G, Sawyer JR, Jagannath S, Desikan KR, Siegel D, Naucke S, Mattox S, Bracy D, Munshi N, Barlogie B: Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants. J Clin Oncol 15:2659, 1997